Our Board of Directors, management team and employees recognize the importance of key ESG issues that drive the long-term sustainability of our business for the benefit of all our stakeholders. Over the past several years, we have taken steps to formalize our approach to ESG. Our inaugural ESG report provides a summary of where we stand today along with insights into our future efforts. In developing the report, we were guided by leading ESG reporting frameworks such as the Sustainability Accounting Standards Board (SASB) standard for the Medical Equipment & Supplies industry, and our report includes an index with SASB-aligned disclosures.

“We strive to continuously improve the supply and post-transplant clinical outcomes for organ transplant patients, and we want to do so by operating responsibly and sustainably. Our inaugural ESG report lays the groundwork for building on our performance and our record of transparency in the years ahead.”

– Waleed Hassanein, M.D., President, and Chief Executive Officer.